Janus Henderson Group
London, Coloradojanushenderson.com
Overview
Janus Henderson Group is a global asset management firm formed through the 2017 merger of Janus Capital Group and Henderson Group, offering a range of financial products across equities, fixed income, multi-asset, and alternatives to individuals, intermediary advisors, and institutional investors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Soufflé Therapeutics | Oct 2026 | Series B | Co-investor |
| Tare | Sep 2026 | Seed | Co-investor |
| Encoded Therapeutics | Sep 2026 | Series F | Co-investor |
| Form Energy | Aug 2026 | Series G | Co-investor |
| Epicrispr Biotechnologies | Aug 2026 | Series C | Lead |
Key People
Amy J. Boyle
Senior People Business Partner
Myron Scholes
Chief Investment Strategist
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?